xAnts

Breakthrough Sleep Apnea Treatment: FDA Approves Lilly's Zepbound

In a significant development for the millions of Americans affected by sleep apnea, the FDA has approved Lilly's Zepbound, a novel GLP-1 agonist. This innovative treatment offers new hope for the 25 million individuals struggling with sleep apnea, of ...undefined